CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Taiwan

  • Pages: 191
  • Published: August 2017
  • Format:
  • Report Code: GDHC0080CHR
  • Add to Saved List

Invite Credit Card Holder to pay

Requester Details

Credit Card Holder Details

Company Details

Message to be included

GlobalData, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Taiwan”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Taiwan. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Taiwan’s population grew from 23.12 million in 2009 to 23.54 million in 2016, mainly due to the increase in the life expectancy. The value of the pharmaceuticals market increased from $2.40 billion in 2009 to $2.42 billion in 2016 at a Compound Annual Growth Rate (CAGR) of 0.12%, and this value is expected to increase further from $2.43 billion in 2017 to $2.44 billion in 2021 at a CAGR of 0.12%. The medical device market was worth $2 billion in 2016 and is projected to reach $2.54 billion by 2021 at a CAGR of 4.9%.

These positive growth trends can be primarily attributed to:

  • An increasingly elderly population
  • Universal health coverage
  • Government initiatives

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Taiwan, and includes:

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: China Chemical & Pharmaceutical Co., Yung Shin Pharma, TTY Biopharm, Standard Chem & Pharm Co., and Taiwan Biotech; and of major players in the medical device market: Baxter International, Fresenius, Osstem Implant, Nobel Biocare, and Ivoclar Vivadent
  • An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the country’s political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Taiwanese healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

  • Develop business strategies by understanding the trends shaping and driving Taiwan’s healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Taiwan’s healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Executive Summary

3 Introduction

3.1 GlobalData Report Guidance

4 ...

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Executive Summary

3 Introduction

3.1 GlobalData Report Guidance

4 Overview of Pharmaceutical and Medical Device Markets

4.1 Pharmaceutical Market

4.1.1 Market Overview

4.1.2 Pharmaceutical Exports and Imports

4.1.3 Supply Channels

4.1.4 Market Segments

4.1.5 Overview of Top Five Disease Areas

4.1.6 Major Players

4.2 Medical Device Market

4.2.1 Market Overview

4.2.2 Overview of Top Five Segments

4.2.3 Major Players

4.3 Market Drivers and Barriers

4.3.1 Drivers

4.3.2 Barriers

5 Market Access

5.1 Overview of Healthcare system

5.1.1 Reimbursement Process

5.1.2 Overview of Insurance Providers

5.1.3 Patient Share in Healthcare Expenditure

5.1.4 Price Trends in the Healthcare Sector

5.1.5 Pricing Policies

5.2 Regulatory Landscape

5.2.1 Overview of Regulatory Agencies

5.2.2 Market Authorization Procedure for Pharmaceutical Products

5.2.3 Market Authorization Procedure for Medical Devices

5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing

5.2.5 Licensing Process for Pharmaceutical Exports and Imports

5.2.6 Intellectual Property Rights

5.2.7 Clinical Trial Regulations

5.2.8 Pharmaceutical Advertising Regulations

5.2.9 Pharmacy Regulations

5.2.10 Labeling and Packaging Regulations

6 Country Analysis

6.1 Political Environment

6.1.1 Political Structure

6.1.2 Current Political Environment

6.1.3 Healthcare Policy Initiatives

6.2 Economic Landscape

6.3 Economic Indicators

6.3.1 Gross Domestic Product

6.3.2 Gross National Income

6.3.3 Inflation

6.3.4 Currency Exchange Rate

6.3.5 Foreign Direct Investment

6.3.6 Foreign Exchange Reserves

6.3.7 Trade Balance

6.3.8 Government Structural Balance

6.3.9 Government Net Debt

6.3.10 Major Industries

6.4 Demographics

6.4.1 Population

6.4.2 Education and Literacy

6.4.3 Employment

6.4.4 Disease Burden

6.5 Healthcare Infrastructure

6.5.1 Healthcare Facilities

6.5.2 Healthcare Parameters

6.5.3 Environmental Health

6.5.4 Healthcare Personnel

6.6 Healthcare Expenditure

6.6.1 Overview

6.6.2 Share of Public and Private Sectors

6.7 Trade Associations

6.7.1 Taiwan Medical and Biotech Industry Association

6.7.2 Taiwan Public Health Association

6.7.3 Taiwan Medical Association

6.7.4 Taiwan Generic Pharmaceutical Association

6.8 Trade Fairs

7 Opportunities and Challenges

7.1 Opportunities

7.2 Challenges

8 Appendix

8.1 Abbreviations

8.2 Bibliography

8.3 Research Methodology

8.3.1 Coverage

8.3.2 Secondary Research

8.3.3 Forecasts

8.3.4 Expert Panel

8.4 Contact Us

8.5 Disclaimer

List of tables

Table 1: Pharmaceutical Market, Taiwan, Revenue ($bn), 2009–2016

Table 2: Pharmaceutical Market, Taiwan, Revenue ($bn), 2017–2021

Table 3: Pharmaceutical Market, Taiwan, Exports and ...

Table 1: Pharmaceutical Market, Taiwan, Revenue ($bn), 2009–2016

Table 2: Pharmaceutical Market, Taiwan, Revenue ($bn), 2017–2021

Table 3: Pharmaceutical Market, Taiwan, Exports and Imports ($bn), 2009–2016

Table 4: Pharmaceutical Market, Taiwan, Revenue by Major Therapeutic Areas ($bn), 2014

Table 5: Major Products, CCPC, Taiwan, 2016

Table 6: Pharmaceutical Market, Standard, Taiwan, Major Products, 2016

Table 7: Pharmaceutical Market, Taiwan Biotech, Taiwan, Major Products, 2016

Table 8: Medical Device Market, Taiwan, Revenue ($bn), 2009–2016

Table 9: Medical Device Market, Taiwan, Revenue ($bn), 2017–2021

Table 10: Medical Device Market, Taiwan, Revenue ($m) and Market Share (%) by Segment, 2016

Table 11: Orthopedic Devices Market, Taiwan, Revenue ($m), 2009–2016

Table 12: Orthopedic Devices Market, Taiwan, Revenue ($m) and Market Share (%) of Major Players, 2016

Table 13: Healthcare IT Device Market, Taiwan, Revenue ($m), 2009–2016

Table 14: Healthcare IT Devices, Taiwan, Revenue ($m) and Market Share (%) of Major Players, 2015

Table 15: Ophthalmic Device Market, Taiwan, Revenue ($m), 2009–2016

Table 16: Ophthalmic Devices, Taiwan, Revenue ($m) and Market Share (%) of Major Players, 2015

Table 17: Diagnostic Imaging Devices, Taiwan, Revenue ($m), 2009–2016

Table 18: Diagnostic Imaging Devices, Taiwan, Revenue ($m) and Market Share (%) of Major Players, 2015

Table 19: Cardiovascular Device Market, Taiwan, Revenue ($m), 2009–2016

Table 20: Cardiovascular Device Market, Taiwan, Revenue ($m) and Market Share (%) of Major Players, 2015

Table 21: Medical Device Market, Taiwan, Revenue ($m) and Market Share (%) of Major Players, 2012

Table 22: Medical Device Market, Osstem, Major Products, Global, 2016

Table 23: Medical Device Market, Nobel Biocare, Major Products, Global, 2016

Table 24: Medical Device Market, Ivoclar Vivadent, Major Products, Asia, 2017

Table 25: Market Access, Healthcare System, Taiwan, Premium Contribution Ratios under NHI System, 2016

Table 26: Market Access, Healthcare System, Taiwan, Basic Outpatient Care Co-payments ($), 2016

Table 27: Healthcare Expenditure, Taiwan, Out-of-Pocket Expenditure (%), 2009–2016

Table 28: Market Access, Taiwan, Healthcare Consumer Price Index Annual Change (%), 2009–2016

Table 29: Healthcare System, Taiwan, Registration Fee Structure for New Drug Application ($), 2017

Table 30: Healthcare System, Taiwan, Regulatory Requirement for Medical Devices, 2013

Table 31: Healthcare System, Taiwan, Medical Equipment Classification, 2016

Table 32: Healthcare System, Taiwan, Schedule of Patent Fees, 2017

Table 33: Market Access, Taiwan, Schedule of Trademark Fees, 2017

Table 34: Economic Indicators, Taiwan, GDP per Capita ($), 2009–2016

Table 35: Economic Indicators, Taiwan, GDP per Capita ($), 2017–2021

Table 36: Economic Indicators, Taiwan, GDP Annual Growth (%), 2009–2016

Table 37: Economic Indicators, Taiwan, GDP Annual Growth (%), 2017–2021

Table 38: Economic Indicators, Taiwan, GNI per Capita ($), 2009–2016

Table 39: Economic Indicators, Taiwan, Consumer Price Index, 2009–2016

Table 40: Economic Indicators, Taiwan, Average Consumer Price Index, 2017–2021

Table 41: Economic Indicators, Taiwan, Average Consumer Price Index Annual Change (%), 2009–2016

Table 42: Economic Indicators, Taiwan, Average Consumer Price Index, Annual Change (%), 2017–2021

Table 43: Economic Indicators, Taiwan, Currency Exchange Rate (TWD/$), 2009–2016

Table 44: Economic Indicators, Taiwan, Foreign Direct Investment ($bn), 2009–2016

Table 45: Economic Indicators, Taiwan, Foreign Exchange Reserves ($bn), 2009–2016

Table 46: Economic Indicators, Taiwan, Imports of Goods and Services ($bn), 2009–2016

Table 47: Economic Indicators, Taiwan, Exports of Goods and Services ($bn), 2009–2016

Table 48: Economic Indicators, Taiwan, General Government Structural Balance ($bn), 2009–2016

Table 49: Economic Indicators, Taiwan, Government Net Debt as a Percentage of GDP (%), 2009–2016

Table 50: Economic Indicators, Taiwan, Government Net Debt as a Percentage of GDP (%), 2017–2021

Table 51: Economic Indicators, Taiwan, Value Added by Major Industries ($bn), 2015

Table 52: Demographics, Taiwan, Population (million), 2009–2016

Table 53: Demographics, Taiwan, Population (million), 2017–2021

Table 54: Demographics, Taiwan, Urban–Rural Population Share (%), 2009–2016

Table 55: Demographics, Taiwan, Urban–Rural Population Share (%), 2017–2021

Table 56: Demographics, Taiwan, Population Distribution by Age Group (%), 2009–2016

Table 57: Demographics, Taiwan, Population Distribution by Age Group (%), 2017–2021

Table 58: Demographics, Taiwan, Births (per 1,000 Population), 2009–2016

Table 59: Demographics, Taiwan, Mortality (per 1,000 Population), 2009–2016

Table 60: Demographics, Taiwan, Major Causes of Mortality (%), 2015

Table 61: Demographics, Taiwan, Mortality Rate of Children Under One (per 1,000 live births), 2009–2016

Table 62: Demographics, Taiwan, Immunization Coverage (%), 2015

Table 63: Demographics, Taiwan, Gender Ratio (M/F), 2009–2016

Table 64: Demographics, Taiwan, Life Expectancy at Birth (years), 2009–2016

Table 65: Demographics, Taiwan, Life Expectancy at Birth (years), 2017–2021

Table 66: Demographics, Taiwan, Student Net Enrollment by Level of Education (%), 2016

Table 67: Demographics, Taiwan, Unemployment Rate (%), 2009–2016

Table 68: Demographics, Taiwan, Employment by Sector (‘000), 2015

Table 69: Demographics, Taiwan, Personal Health Expenditure by Disease (%), 2014

Table 70: Healthcare Infrastructure, Taiwan, Hospitals, 2009–2016

Table 71: Healthcare Infrastructure, Taiwan, Public and Private Hospitals, 2009–2016

Table 72: Healthcare Infrastructure, Taiwan, Public Hospitals, Share by Ownership (%), 2015

Table 73: Healthcare Infrastructure, Taiwan, Private Hospitals, Share by Ownership (%), 2015

Table 74: Healthcare Infrastructure, Taiwan, Hospitals by Standard of Care, Contracted by NHIA, 2009–2016

Table 75: Healthcare Infrastructure, Taiwan, Hospitals by Services Rendered, 2015

Table 76: Healthcare Infrastructure, Taiwan, Beds by Type of Hospital, 2009–2016

Table 77: Healthcare Infrastructure, Taiwan, Beds by Specialty Care, 2015

Table 78: Healthcare Infrastructure, Taiwan, Diagnostic Centers, 2009–2016

Table 79: Healthcare Infrastructure, Taiwan, Hospitals Beds (per 10,000 population), 2009–2016

Table 80: Healthcare Infrastructure, Taiwan, Number of Doctors, 2009–2016

Table 81: Healthcare Infrastructure, Taiwan, CO2 Emissions (kilotons per year), 2009–2016

Table 82: Healthcare Infrastructure Taiwan, Nurses, 2009–2016

Table 83: Healthcare Infrastructure, Taiwan, Pharmacists, 2009–2016

Table 84: Healthcare Infrastructure, Taiwan, Dentists, 2009–2016

Table 85: Healthcare Infrastructure, Taiwan, Healthcare Expenditure as Percentage of GDP (%), 2009–2016

Table 86: Healthcare Infrastructure, Taiwan, Public–Private Share of Expenditure (%), 2009–2016

Table 87: Healthcare Expenditure, Taiwan, Major Healthcare Trade Fairs, 2017

List of figures

Figure 1: Pharmaceutical Market, Taiwan, Revenue ($bn), 2009–2021

Figure 2: Medical Device Market, Taiwan, Revenue ($bn), 2009–2021

Figure 3: Country Profile, Taiwan, 2017 ...

Figure 1: Pharmaceutical Market, Taiwan, Revenue ($bn), 2009–2021

Figure 2: Medical Device Market, Taiwan, Revenue ($bn), 2009–2021

Figure 3: Country Profile, Taiwan, 2017

Figure 4: Pharmaceutical Market, Taiwan, Revenue ($bn), 2009–2016

Figure 5: Pharmaceutical Market, Taiwan, Revenue ($bn), 2017–2021

Figure 6: Pharmaceutical Market, Taiwan, Exports and Imports ($bn), 2009–2016

Figure 7: Pharmaceutical Market, Taiwan, Revenue by Major Therapeutic Areas ($bn), 2014

Figure 8: Medical Device Market, Taiwan, Revenue ($bn), 2009–2016

Figure 9: Medical Device Market, Taiwan, Revenue ($bn), 2017–2021

Figure 10: Medical Device Market, Taiwan, Revenue by Segment ($m), 2016

Figure 11: Orthopedic Devices Market, Taiwan, Revenue ($m), 2009–2016

Figure 12: Orthopedic Devices Market, Taiwan, Market Share of Major Players (%), 2016

Figure 13: Healthcare IT Device Market, Taiwan, Revenue ($m), 2009–2016

Figure 14: Healthcare IT Device Market, Taiwan, Market Share of Major Players (%), 2015

Figure 15: Ophthalmic Device Market, Taiwan, Revenue ($m), 2009–2016

Figure 16: Ophthalmic Devices, Taiwan, Market Share of Major Players (%), 2015

Figure 17: Diagnostic Imaging Devices, Taiwan, Revenue ($m), 2009–2016

Figure 18: Diagnostic Imaging Devices, Taiwan, Market Share of Major Players (%), 2015

Figure 19: Cardiovascular Device Market, Taiwan, Revenue ($m), 2009–2016

Figure 20: Cardiovascular Device Market, Taiwan, Market Share of Major Players (%), 2016

Figure 21: Medical Device Market, Taiwan, Revenue of Major Players ($m), 2012

Figure 22: Healthcare Market, Taiwan, Drivers and Barriers, 2017

Figure 23: Market Access, Healthcare System, Taiwan, Organizational Structure of NHI, 2016

Figure 24: Market Access, Healthcare System, Taiwan, Evolution of Healthcare System, 2016

Figure 25: Market Access, Healthcare System, Taiwan, HTA Assessment for Application of NHI New Drug Listing, 2016

Figure 26: Market Access, Healthcare System, Taiwan, Process for Coverage and Reimbursement of Medical Devices, 2016

Figure 27: Market Access, Healthcare System, Taiwan, NHI System, 2016

Figure 28: Market Access, Healthcare System, Taiwan, Premium Collection under Second-Generation NHI System, 2016

Figure 29: Healthcare Expenditure, Taiwan, Out-of-Pocket Expenditure (%), 2009–2016

Figure 30: Market Access, Taiwan, Healthcare Consumer Price Index Annual Change (%), 2009–2016

Figure 31: Market Access, Taiwan, Organizational Structure of Center for Drug Evaluation, 2017

Figure 32: Market Access, Taiwan, Drug Review Process for NDA, 2017

Figure 33: Market Access, Taiwan, Total Product Life Cycle Management Process, 2017

Figure 34: Market Access, Taiwan, Marketing Authorization Procedure for Medical Devices, 2013

Figure 35: Market Access, Taiwan, IVD Registration Application Process, 2017

Figure 36: Market Access, Taiwan, Clinical Trial Regulation Process for an Investigational New Drug, 2014

Figure 37: Economic Indicators, Taiwan, GDP Per Capita ($), 2009–2016

Figure 38: Economic Indicators, Taiwan, GDP per Capita ($), 2017–2021

Figure 39: Economic Indicators, Taiwan, GDP Annual Growth (%), 2009–2016

Figure 40: Economic Indicators, Taiwan, GDP Annual Growth (%), 2017–2021

Figure 41: Economic Indicators, Taiwan, GNI per Capita ($), 2009–2016

Figure 42: Economic Indicators, Taiwan, Consumer Price Index, 2009–2016

Figure 43: Economic Indicators, Taiwan, Average Consumer Price Index, 2017–2021

Figure 44: Economic Indicators, Taiwan, Average Consumer Price Index, Annual Change (%), 2009–2016

Figure 45: Economic Indicators, Taiwan, Average Consumer Price Index, Annual Change (%), 2017–2021

Figure 46: Economic Indicators, Taiwan, Currency Exchange Rate (TWD/$), 2009–2016

Figure 47: Economic Indicators, Taiwan, Foreign Direct Investment ($bn), 2009–2016

Figure 48: Economic Indicators, Taiwan, Foreign Exchange Reserves ($bn), 2009–2016

Figure 49: Economic Indicators, Taiwan, Imports of Goods and Services ($bn), 2009–2016

Figure 50: Economic Indicators, Taiwan, Exports of Goods and Services ($bn), 2009–2016

Figure 51: Economic Indicators, Taiwan, Government Structural Balance ($bn), 2009–2016

Figure 52: Economic Indicators, Taiwan, Government Net Debt as a Percentage of GDP (%), 2009–2016

Figure 53: Economic Indicators, Taiwan, Government Net Debt as a Percentage of GDP (%), 2017–2021

Figure 54: Economic Indicators, Taiwan, Value Added by Major Industries ($bn), 2015

Figure 55: Demographics, Taiwan, Population (million), 2009–2016

Figure 56: Demographics, Taiwan, Population (million), 2017–2021

Figure 57: Demographics, Taiwan, Urban–Rural Population Share (%), 2009–2016

Figure 58: Demographics, Taiwan, Urban–Rural Population Share (%), 2017–2021

Figure 59: Demographics, Taiwan, Population Distribution by Age Group (%), 2009–2016

Figure 60: Demographics, Taiwan, Population Distribution by Age Group (%), 2017–2021

Figure 61: Demographics, Taiwan, Births (per 1,000 Population), 2009–2016

Figure 62: Demographics, Taiwan, Mortality (per 1,000 Population), 2009–2016

Figure 63: Demographics, Taiwan, Major Causes of Mortality (%), 2015

Figure 64: Demographics, Taiwan, Mortality Rate of Children Under One (per 1,000 live births), 2009–2016

Figure 65: Demographics, Taiwan, Immunization Coverage (%), 2015

Figure 66: Demographics, Taiwan, Gender Ratio (M/F), 2009–2016

Figure 67: Demographics, Taiwan, Life Expectancy at Birth (years), 2009–2016

Figure 68: Demographics, Taiwan, Life Expectancy at Birth (years), 2017–2021

Figure 69: Demographics, Taiwan, Student Net Enrollment by Level of Education (%), 2016

Figure 70: Demographics, Taiwan, Unemployment Rate (%), 2009–2016

Figure 71: Demographics, Taiwan, Employment by Sector (‘000), 2015

Figure 72: Demographics, Taiwan, Personal Health Expenditure by Disease (%), 2014

Figure 73: Healthcare Infrastructure, Taiwan, Hospitals, 2009–2016

Figure 74: Healthcare Infrastructure, Taiwan, Public and Private Hospitals, 2009–2016

Figure 75: Healthcare Infrastructure, Taiwan, Public Hospitals, Share by Ownership (%), 2015

Figure 76: Healthcare Infrastructure, Taiwan, Private Hospitals, Share by Ownership (%), 2015

Figure 77: Healthcare Infrastructure, Taiwan, Hospitals by Standard of Care, Contracted by NHIA, 2009–2016

Figure 78: Healthcare Infrastructure, Taiwan, Hospitals by Services Rendered (%), 2015

Figure 79: Healthcare Infrastructure, Taiwan, Beds by Type of Hospital, 2009–2016

Figure 80: Healthcare Infrastructure, Taiwan, Beds by Specialty Care, 2015

Figure 81: Healthcare Infrastructure, Taiwan, Diagnostic Centers, 2009–2016

Figure 82: Healthcare Infrastructure, Taiwan, Hospitals Beds (per 10,000 population), 2009–2016

Figure 83: Healthcare Infrastructure, Taiwan, Number of Doctors, 2009–2016

Figure 84: Healthcare Infrastructure, Taiwan, CO2 Emissions (kilotons per year), 2009–2016

Figure 85: Healthcare Infrastructure, Taiwan, Nurses, 2009–2016

Figure 86: Healthcare Infrastructure, Taiwan, Pharmacists, 2009–2016

Figure 87: Healthcare Infrastructure, Taiwan, Dentists, 2009–2016

Figure 88: Healthcare Infrastructure, Taiwan, Healthcare Expenditure as Percentage of GDP (%), 2009–2016

Figure 89: Healthcare Infrastructure, Taiwan, Public–Private Share of Expenditure (%), 2009–2016

Figure 90: Healthcare Market, Taiwan, Opportunities and Challenges, 201

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Saved reports

Syndicated reports are detailed with easy referencing, and even the forecast models are detailed with analyst references along with most comprehensive M&A database

  Adamas Pharmaceuticals, Inc.